Article
Spatial immune ecosystems govern therapeutic response in HER2-low breast cancer
2026-08-24
Abstract excerpt
HER2 low breast cancer represents a clinically important but biologically heterogeneous disease state, and the spatial immune programs underlying therapeutic response remain poorly understood. Here, we used single-cell spatial transcriptomics to characterize HER2 low and HER2 high breast tumors and define microenvironmental features associated with treatment sensitivity and resistance. We identified diverse malign...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 40cc6891-d2a0-5741-9aa0-1dff3d7d8cba
- DOI
- 10.64898/2026.08.19.745800
